Company news

Prescient Therapeutics Limited news in 2022

Prescient Therapeutics Limited's news releases, calls and decks from 2022, newest first.

View company

AGM Presentation

November 29, 2022

September 2022 Quarterly Update and Appendix 4C

October 30, 2022

PTX-100 Trial Update

October 24, 2022

Placement Results

October 10, 2022

SPP Results and Placement

October 6, 2022

PTX unveils CellPryme-A to boost CAR-T performance

September 22, 2022

PTX strategic collaboration with MD Anderson Cancer Center

September 6, 2022

Prescient Therapeutics Launches Share Purchase Plan

August 24, 2022

Appendix 4E and 2022 Annual Report

August 23, 2022

PTX agreement with Thermo Fisher for scalable OmniCAR

August 17, 2022

PTX OmniCAR cell manufacturing contract for clinical trials

August 15, 2022

June 2022 Quarterly Update and Appendix 4C

July 24, 2022

US FDA Grants Orphan Drug Designation to PTX-100 for PTCL

July 14, 2022

Key OmniCAR Patent Granted in US

July 4, 2022

PTX CellPryme-M presentation

June 7, 2022

PTX unveils new clinic-ready CAR-T enhancement platform

June 7, 2022

PTX-200 AML expansion after another complete response

May 9, 2022

March 2022 Quarterly Update and Appendix 4C

April 28, 2022

Recruitment Open for Expansion Cohort of Phase 1B Study

April 5, 2022

December 2021 Quarterly Update and Appendix 4C

January 30, 2022

Decks in 2022